Immunotherapy with CAR-T cells in paediatric haematology-oncology

Immunotherapy with CAR-T cells in paediatric haematology-oncology

Despite being a rare disease, cancer is the first cause of mortality due to disease during the paediatric age in the developed countries. The current, great increase in new treatments, such as immunotherapy, constitutes a new clinical and regulatory paradigm. Cellular immunotherapy is one of these t...

Full description

Bibliographic Details
Main Authors: Isabel Mirones, Lucas Moreno, Ana Patiño-García, Garbiñe Lizeaga, José M. Moraleda, María Luisa Toribio, Antonio Pérez-Martínez, Luisa Sisinni, Marina García-Morín, Javier Anguita, Manuel Ramírez, Laura Alonso, Susana Rives, Marta M. Alonso, Pilar Palomo, Jaime Verdú-Amorós, Isabel Martínez, Pilar Guerra-García, José Luis Fuster, Andrés Sánchez-Salinas, Miguel Blanquer, Javier García-Castro, María Luisa Toribio e Hisse M. van Santen, Pablo Menéndez
Format: Article
Language:Spanish
Published: Elsevier 2020-07-01
Series:Anales de Pediatría (English Edition)
Subjects:
Inmunoterapia
Células CAR-T
Cáncer
Terapias avanzadas
Online Access:http://www.sciencedirect.com/science/article/pii/S234128792030082X

Internet

http://www.sciencedirect.com/science/article/pii/S234128792030082X

Similar Items